Skip to content

Management & founders

We are a comprehensive mix of experienced scientists and entrepreneurs. Our team brings together expertise in the medical and pharmaceutical industries as well as in the computer technology and business-to-business software sectors.
Kaisa Helminen
CEO

Kaisa Helminen, M.Sc, is the CEO of Aiforia Technologies Oy. Kaisa joined Fimmic in 2014 and has previously worked for international companies Sartorius, Thermo Fisher Scientific Inc. and a Finnish biotech company Finnzymes Oy. Kaisa has a strong background in life science sector where she has gained almost 20 years of experience in the global business. She has wealth of experience in global sales, marketing and strategic product management in life science businesses.

Johan Lundin
CSO, Co-founder

Johan Lundin, MD and PhD, is one of the co-founders of Aiforia. He works as the Chief Scientific Officer at Aiforia Technologies Oy. Johan is also a Research Director at Finnish Institute for Molecular Medicine (FIMM) at University of Helsinki. For more than 15 years, Johan has developed technologies for diagnostic decision support with cloud-based and mobile solutions that allow the diagnostic process to be performed remotely, by a human observer or using automated computerized analysis.

Mikael Lundin
Director of Concept Design, Co-founder

Mikael Lundin, MD, is one of the co-founders of Aiforia. He works as the Director of Concept Design at Aiforia Technologies Oy. Mikael is a pioneer in web-based virtual microscopy and has launched the first practical applications in 2002. He has published a series of central studies in virtual microscopy together with key opinion leaders in related fields. Mikael is fluent in a wide range of programming languages, and he has a special interest in database design and imaging.

Kari Pitkänen
Director of Business Development, Co-founder

Kari Pitkänen, M.Sc.Tech, is one of the co-founders of Aiforia. He works as a Director of Business Development at Aiforia Technologies Oy. Kari is an experienced life-science entrepreneur. He was one of the founders and Director of Marketing in Finnzymes Oy for 25 years, until its acquisition by Thermo Fisher Scientific in 2010.

Tuomas Ropponen
Chief Technology Officer

Tuomas Ropponen, M.Sc.Tech, is the Chief Technology Officer at Aiforia Technologies Oy. Tuomas has extensive experience in developing deep learning AI and machine vision based systems and cloud infrastructures. He has previously worked for more than 15 years in international companies Outotec and Sartorius Biohit. Tuomas was one of the founders of Delta-Enterprise, known today as Roima Intelligence Inc.

Bill Maloy
US Sales Director

Bill Maloy is the Sales Director for North American operations. His focus is on broadening the company’s reach within the pharmaceutical and research industries across the region and building long term strategic partnerships with our customers. Bill has close to 20 years experience in sales and marketing within cloud and SaaS based startups with a focus on the life sciences sector, such as Cartagenia & GenomeQuest.

Thomas Westerling-Bui
Senior Scientist, Regional Business Development

Thomas Westerling-Bui received his PhD in cancer biology, focusing on the cell cycle and transcription, from the University of Helsinki Medical School in Finland. He completed a post-doctoral EMBO fellowship at the Dana Farber Cancer Institute in Boston, researching the genomics of breast and prostate cancer. Tom joined Aiforia to advance the new potential of cancer biology, pathology, big data, and artificial intelligence.

Mikael Jääskeläinen
Sales Manager

Mikael Jääskeläinen is responsible for global sales and customer relations management for Aiforia Technologies Oy. Mikael joined Aiforia in March 2014 having previously worked for international companies Sartorius, Thermo Fisher Scientific Inc. and Finnish biotech company Finnzymes Oy. Mikael has more than 25 years of experience in sales and marketing in the life science sector.

Our board

Pekka Mattila
Chairman of the board

Pekka Mattila is the CEO of Desentum Oy. He holds board positions in several biotech and pharmaceutical companies. He is one of the founders of Finnzymes Group and served as its CEO for 25 years until its acquisition by Thermo Fisher Scientific in 2010.

Monita Mo
Board member

Monita Mo is a Hong Kong native with a professional career in Arthur Andersen NYC. She is a serial entrepreneur who has started three successful companies, including Ascend Capital Partners. She founded her own accounting firm in NYC in 1992 and her second company, Ascend Capital Partners in Beijing in 2002.

Johan Lundin
Board member

Johan Lundin, MD and PhD, is one of the founders of Aiforia. At Aiforia Technologies Oy Johan works as the Chief Scientific Officer. Johan is also a Research Director at Finnish Institute of Molecular Medicine (FIMM) at  the University of Helsinki.

Timo Soininen
Board member

Timo Soininen is the CEO and co-founder of rapidly growing gaming company, Small Giant Games. Timo is an experienced international digital growth executive and a startup activist with a strong concept building background.

Jukka Tapaninen
Board member

Jukka Tapaninen is an experienced IT business executive currently working as the VP&Managing Director EMEA, APAC and Japan at Pegasystems Inc.  Jukka has a strong background in the IT industry, including SAP, HP, on managing companies and business units globally.